Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Sugar vs. sweetener showdown: which is better for your blood sugar?

NCT ID NCT07656298

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares how natural sugar (sucrose) and the artificial sweetener sucralose affect blood sugar control and metabolism in 120 adults with normal weight, overweight, or obesity. Participants will consume low or high doses of each sweetener in solid or liquid form over 12-week periods. The goal is to see if responses differ by body weight, dose, or how the sweetener is consumed.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
sucrose (natural sugar) and sucralose (artificial sweetener)
What this could lead to
If successful, this could clarify whether artificial sweeteners are better or worse for metabolism than natural sugar, and how dose and form (solid vs. liquid) matter.
What could go wrong
This is an early-stage observational study with only 120 participants, so results may not apply to everyone. It measures short-term effects, not long-term health outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 120 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

Sep 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18 to 65 years at the time of enrollment. * Body Mass Index (BMI) between 18.5 and 39.9 kg/m². * Men and women who report a preference for sweet taste and habitual consumption of sugar and/or sweeteners. * Individuals in good general health, as determined by: 1. Medical history and clinical evaluation; 2. Absence of uncontrolled chronic diseases, such as diabetes, metabolic syndrome, severe hypertension, or advanced liver or renal disease; and 3. Baseline biochemical parameters within normal reference ranges, including fasting plasma glucose \<100 mg/dL, HbA1c \<5.7%, normal liver and renal function (ALT/AST and creatinine within reference ranges), and blood pressure \<140/90 mmHg without pharmacological treatment. * Less than 4 hours per week of moderate-to-vigorous physical activity. * Not following special or restrictive diets (e.g., ketogenic, strict vegetarian, or vegan diets). * Not taking medications known to affect metabolism, including, for example, antidiabetic drugs, systemic corticosteroids, weight-loss medications, or high-dose antioxidant supplements, except for stable use of hormonal contraceptives. * Willingness to maintain habitual diet and physical activity throughout the study, with the only modification being the assigned sweetener intervention. * Ability and willingness to comply with all study procedures and scheduled visits. * Provision of written informed consent before participation. Exclusion Criteria: * Gastrointestinal disorders influencing digestion or nutrient absorption (e.g., inflammatory bowel disease, celiac disease, malabsorption syndromes). * History of cancer not in remission. * Uncontrolled thyroid disorders. * History of bariatric surgery or extreme weight loss within the past 12 months. * Pregnancy, breastfeeding, or planning pregnancy during the study period. * Acute illness, major infection, hospitalization, or major surgery within the previous 6 months. * Any condition that, in the investigators' judgment, could compromise participant safety, protocol adherence, or interpretation of the study results.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Glucose metabolism are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

glucose metabolism disease Inflammation Obesity obesity disorder Overweight

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Hospital Universitario Virgen de la Victoria

    RECRUITING

    Málaga, Malaga, 29103, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.